Tue, Jul 30, 2024
The company said that 75 per cent of the issue size has been reserved for qualified institutional buyers, 15 per cent for non-institutional investors and the remaining 10 per cent for retail investors.
More >
Thu, Jul 25, 2024
Akums Drugs and Pharma has reserved shares worth Rs 15 crore for its employees in the public issue. Proceeds from the fresh issue will be used to repay debt, to fund working capital requirements of the company, to pursue inorganic growth initiatives through acquisition and for general corporate purposes.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
